Literature DB >> 27125982

Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia.

Thomas Perwein1, Sabine Strehl2, Margit König2, Herwig Lackner1, Renate Panzer-Grümayer3, Georg Mann4, Andishe Attarbaschi4, Ernst-Christian Urban1, Oskar A Haas5.   

Abstract

Entities:  

Keywords:  RCSD1-ABL1-positive; acute lymphoblastic leukemia; imatinib; long-term remission; relapse

Mesh：

Substances：

Year:  2016        PMID： 27125982      PMCID： PMC4967583          DOI： 10.3324/haematol.2015.139568

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  A t(1;9)(q23.3 approximately q25;q34) affecting the ABL1 gene in a biphenotypic leukemia.

Authors:  Juan Ramón González García; Stefan K Bohlander; Melva Gutiérrez Angulo; María Amparo Esparza Flores; Verónica Judith Picos Cárdenas; Juan Pablo Meza Espinoza; María de la Luz Ayala Madrigal; Horacio Rivera
Journal:  Cancer Genet Cytogenet       Date:  2004-07-01

2.  A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.

Authors:  E De Braekeleer; N Douet-Guilbert; M-J Le Bris; C Berthou; F Morel; M De Braekeleer
Journal:  Leukemia       Date:  2007-05-31       Impact factor: 11.528

3.  A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34).

Authors:  Satu Mustjoki; Sari Hernesniemi; Auvo Rauhala; Marketta Kähkönen; Anders Almqvist; Tuija Lundán; Kimmo Porkka
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

4.  The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.

Authors:  Francois P Duhoux; Nathalie Auger; Sigrid De Wilde; Sebastian Wittnebel; Geneviève Ameye; Khadija Bahloula; Catherine Van den Berg; Jeanne-Marie Libouton; Pascale Saussoy; Francis H Grand; Jean-Baptiste Demoulin; Hélène A Poirel
Journal:  Leuk Res       Date:  2011-03-09       Impact factor: 3.156

Review 5.  ABL1 fusion genes in hematological malignancies: a review.

Authors:  Etienne De Braekeleer; Nathalie Douet-Guilbert; David Rowe; Nick Bown; Frédéric Morel; Christian Berthou; Claude Férec; Marc De Braekeleer
Journal:  Eur J Haematol       Date:  2011-03-23       Impact factor: 2.997

6.  TKI dasatinib monotherapy for a patient with Ph-like ALL bearing ATF7IP/PDGFRB translocation.

Authors:  Kenichiro Kobayashi; Naoyuki Miyagawa; Kazumasa Mitsui; Masaki Matsuoka; Yasuko Kojima; Hiroyuki Takahashi; Kaori Ootsubo; Junichi Nagai; Hitomi Ueno; Takeshi Ishibashi; Sara Sultana; Yoko Okada; Shingo Akimoto; Hajime Okita; Kimikazu Matsumoto; Hiroaki Goto; Nobutaka Kiyokawa; Akira Ohara
Journal:  Pediatr Blood Cancer       Date:  2014-11-14       Impact factor: 3.167

7.  Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

Authors:  Kathryn G Roberts; Yongjin Li; Debbie Payne-Turner; Richard C Harvey; Yung-Li Yang; Deqing Pei; Kelly McCastlain; Li Ding; Charles Lu; Guangchun Song; Jing Ma; Jared Becksfort; Michael Rusch; Shann-Ching Chen; John Easton; Jinjun Cheng; Kristy Boggs; Natalia Santiago-Morales; Ilaria Iacobucci; Robert S Fulton; Ji Wen; Marcus Valentine; Cheng Cheng; Steven W Paugh; Meenakshi Devidas; I-Ming Chen; Shalini Reshmi; Amy Smith; Erin Hedlund; Pankaj Gupta; Panduka Nagahawatte; Gang Wu; Xiang Chen; Donald Yergeau; Bhavin Vadodaria; Heather Mulder; Naomi J Winick; Eric C Larsen; William L Carroll; Nyla A Heerema; Andrew J Carroll; Guy Grayson; Sarah K Tasian; Andrew S Moore; Frank Keller; Melissa Frei-Jones; James A Whitlock; Elizabeth A Raetz; Deborah L White; Timothy P Hughes; Jaime M Guidry Auvil; Malcolm A Smith; Guido Marcucci; Clara D Bloomfield; Krzysztof Mrózek; Jessica Kohlschmidt; Wendy Stock; Steven M Kornblau; Marina Konopleva; Elisabeth Paietta; Ching-Hon Pui; Sima Jeha; Mary V Relling; William E Evans; Daniela S Gerhard; Julie M Gastier-Foster; Elaine Mardis; Richard K Wilson; Mignon L Loh; James R Downing; Stephen P Hunger; Cheryl L Willman; Jinghui Zhang; Charles G Mullighan
Journal:  N Engl J Med       Date:  2014-09-11       Impact factor: 91.245

Review 8.  Role of ABL family kinases in cancer: from leukaemia to solid tumours.

Authors:  Emileigh K Greuber; Pameeka Smith-Pearson; Jun Wang; Ann Marie Pendergast
Journal:  Nat Rev Cancer       Date:  2013-07-11       Impact factor: 60.716

Review 9.  Imatinib: a breakthrough of targeted therapy in cancer.

Authors:  Nida Iqbal; Naveed Iqbal
Journal:  Chemother Res Pract       Date:  2014-05-19

10.  Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.

Authors:  Y Collette; T Prébet; A Goubard; J Adélaïde; R Castellano; N Carbuccia; S Garnier; A Guille; C Arnoulet; A Charbonier; M J Mozziconacci; D Birnbaum; M Chaffanet; N Vey
Journal:  Blood Cancer J       Date:  2015-03-13       Impact factor: 11.037
View more
  6 in total

1.  Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia.

Authors:  Miriam Frech; Lutz B Jehn; Kathleen Stabla; Stephan Mielke; Björn Steffen; Hermann Einsele; Stephan K Metzelder; Andreas Neubauer
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

Review 2.  New Approaches to Treating Challenging Subtypes of ALL in AYA Patients.

Authors:  Kevin Prescott; Michael Jacobs; Wendy Stock; Joseph Wynne
Journal:  Curr Hematol Malig Rep       Date:  2020-12       Impact factor: 3.952

3.  In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed.

Authors:  Fabian Eberle; Florian H Leinberger; Miriam F Saulich; Werner Seeger; Rita Engenhart-Cabillic; Jörg Hänze; Katja Hattar; Ekkehard Dikomey; Florentine S B Subtil
Journal:  Clin Transl Radiat Oncol       Date:  2017-02-28

Review 4.  New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia.

Authors:  Jan Starý; Jan Zuna; Marketa Zaliova
Journal:  F1000Res       Date:  2018-09-28

Review 5.  The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia.

Authors:  Parveen Shiraz; Kimberly J Payne; Lori Muffly
Journal:  Int J Mol Sci       Date:  2020-03-22       Impact factor: 5.923

Review 6.  How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia.

Authors:  Avraham Frisch; Yishai Ofran
Journal:  Haematologica       Date:  2019-10-03       Impact factor: 9.941
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.